📰 Vcel News
Page 5 - Vcel News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Vcel. Real-time updates on events, politics, business and more.
May 13, 2023
Vericel Co. (NASDAQ:VCEL – Get Rating) – Equities researchers at HC Wainwright reduced their Q4 2023 earnings estimates for Vericel in a research report issued on Thursday, May 11th. HC Wainwright analyst S. Ramakanth now expects that the biotechnology company will post earnings of $0.11 per share for the quarter, down from their prior estimate […]
May 12, 2023
Vericel Co. (NASDAQ:VCEL – Get Rating) – Equities research analysts at HC Wainwright lowered their Q4 2023 earnings per share estimates for Vericel in a report released on Thursday, May 11th. HC Wainwright analyst S. Ramakanth now anticipates that the biotechnology company will post earnings per share of $0.11 for the quarter, down from their […]
May 3, 2023
Vericel (NASDAQ:VCEL – Get Rating) will be posting its quarterly earnings results before the market opens on Wednesday, May 10th. Analysts expect Vericel to post earnings of ($0.13) per share for the quarter. Vericel has set its FY 2023 guidance at EPS.Investors interested in listening to the company’s conference call can do so using this […]
April 23, 2023
Fisher Asset Management LLC grew its stake in Vericel Co. (NASDAQ:VCEL – Get Rating) by 23.8% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,760,522 shares of the biotechnology company’s stock after purchasing an additional 338,887 shares during the period. Fisher Asset Management […]
April 14, 2023
Ingalls & Snyder LLC lowered its holdings in shares of Vericel Co. (NASDAQ:VCEL – Get Rating) by 23.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 27,201 shares of the biotechnology company’s stock after selling 8,555 shares during the quarter. Ingalls & […]
April 6, 2023
Bank of New York Mellon Corp lifted its stake in shares of Vericel Co. (NASDAQ:VCEL – Get Rating) by 2.4% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 417,925 shares of the biotechnology company’s stock after purchasing an additional 9,635 […]
April 6, 2023
MetLife Investment Management LLC cut its holdings in shares of Vericel Co. (NASDAQ:VCEL – Get Rating) by 3.4% during the fourth quarter, HoldingsChannel.com reports. The fund owned 25,551 shares of the biotechnology company’s stock after selling 896 shares during the period. MetLife Investment Management LLC’s holdings in Vericel were worth $673,000 at the end of […]
July 5, 2022
State of Alaska Department of Revenue lessened its stake in Vericel Co. (NASDAQ:VCEL – Get Rating) by 1.5% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 32,652 shares of the biotechnology company’s stock after selling 495 shares during the […]
June 4, 2022
Shares of Vericel Co. (NASDAQ:VCEL – Get Rating) have received an average rating of “Hold” from the six analysts that are covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell rating, two have given a hold rating and two have given a buy rating to the company. The average […]
June 2, 2022
Equities research analysts expect that Vericel Co. (NASDAQ:VCEL – Get Rating) will post earnings per share of ($0.10) for the current quarter, Zacks Investment Research reports. Three analysts have issued estimates for Vericel’s earnings, with estimates ranging from ($0.13) to ($0.03). Vericel posted earnings of ($0.08) per share during the same quarter last year, which […]